Literature DB >> 16290278

Hepatitis B virus-neutralizing anti-pre-S1 human antibody fragments from large naïve antibody phage library.

Sae-Gwang Park1, Yong-Joo Jeong, Yong-Yi Lee, Ik-Jung Kim, Su-Kil Seo, Eui-Joong Kim, Heung-Chae Jung, Jae-Gu Pan, Sung-Jae Park, Yeon-Jae Lee, Ik-Sang Kim, In-Hak Choi.   

Abstract

We report the construction of a large nonimmunized human phage antibody library in single-chain variable region fragment (scFv) format, which allowed the selection of antibodies that neutralize hepatitis B virus (HBV) in vitro. We generated 1.1 x 10(10) independent scFv clones using the cDNA of functional variable (V) gene segments of heavy and light chains purified from the peripheral blood mononuclear cells of 50 nonimmunized human donors. Using BIAcore, we selected two clones that recognized pre-S1 and neutralized pre-S1 and HBV binding to Chang liver cells. Clone G10 had the highest affinity (K(D)=1.69 x 10(-7)M), which was higher than that of clone 1E4 that was generated previously from a heavy chain-shuffled immune library. The off-rates of clones were within 10(-3)s(-1) as determined by BIAcore and were comparable to those of antibodies derived from a normal secondary immune response. In the inhibition assays of pre-S1 and virus binding to Chang liver cells using flow cytometry and the polymerase chain reaction, G10 had better neutralizing activity than 1E4. The new phage library may be a valuable source of antibodies with reasonable affinities to different targets, and the anti-pre-S1 G10 may be a good candidate for immunoprophylaxis against HBV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16290278     DOI: 10.1016/j.antiviral.2005.06.012

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  7 in total

1.  Single-chain antibody fragment specific for Plasmodium vivax Duffy binding protein.

Authors:  So-Hee Kim; Seung-Young Hwang; Yong-Seok Lee; In-Hak Choi; Sae-Gwang Park; Weon-Gyu Kho
Journal:  Clin Vaccine Immunol       Date:  2007-04-25

Review 2.  Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection.

Authors:  Babak Bakhshinejad; Majid Sadeghizadeh
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 3.  Phage display creates innovative applications to combat hepatitis B virus.

Authors:  Wen Siang Tan; Kok Lian Ho
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

4.  Isolation of Neutralizing Human Single Chain Antibodies Against Conserved Hemagglutinin Epitopes of Influenza a Virus H3N2 Strain.

Authors:  Mahboubeh Poursiami; Setareh Moazen; Foroogh Nejatollahi; Afagh Moatari
Journal:  Rep Biochem Mol Biol       Date:  2019-10

5.  The CD39+ HBV surface protein-targeted CAR-T and personalized tumor-reactive CD8+ T cells exhibit potent anti-HCC activity.

Authors:  Fan Zou; Jizhou Tan; Ting Liu; Bingfeng Liu; Yaping Tang; Hui Zhang; Jiaping Li
Journal:  Mol Ther       Date:  2021-01-21       Impact factor: 11.454

Review 6.  The growth and potential of human antiviral monoclonal antibody therapeutics.

Authors:  Wayne A Marasco; Jianhua Sui
Journal:  Nat Biotechnol       Date:  2007-12       Impact factor: 54.908

7.  A toolbox of nanobodies developed and validated for use as intrabodies and nanoscale immunolabels in mammalian brain neurons.

Authors:  Jie-Xian Dong; Yongam Lee; Michael Kirmiz; Stephanie Palacio; Camelia Dumitras; Claudia M Moreno; Richard Sando; L Fernando Santana; Thomas C Südhof; Belvin Gong; Karl D Murray; James S Trimmer
Journal:  Elife       Date:  2019-09-30       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.